Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with GILD as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|14.35%||Merrill Lynch Biotech HOLDRS (BBH)||+21.79 (22.12%)|
|7.46%||iShares NASDAQ Biotechnology Index Fund (IBB)||+59.19 (23.23%)|
|5.36%||Select Sector SPDR Fund - Health Care (XLV)||+8.56 (13.82%)|
|5.13%||First Trust Amex Biotechnology Index Fund (FBT)||+21.24 (25.58%)|
|5.03%||iShares Dow Jones U.S. Health Care Index Fund (IYH)||+18.40 (14.14%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Gilead Sciences, Inc. (Gilead, we or us), incorporated in Delaware on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and experimental drug candidate, we strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's primary areas of focus include human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis B virus (HBV) infection and chronic hepatitis C virus (HCV) infection, oncology/inflammation and serious cardiovascular and respiratory conditions. Headquartered in Foster City, California, we have operations in North and South America, Europe and Asia-Pacific. We continue to add to our existing portfolio of products through our internal discovery and clinical development programs and through a product acquisition and in-licensing strategy. ... More ...